Chalbos D, Haagensen D, Parish T, Rochefort H
Cancer Res. 1987 Jun 1;47(11):2787-92.
Three [35S]methionine-labeled polypeptides released by T47D human breast cancer cells have been identified as corresponding to two proteins previously described in breast gross cystic disease fluid. A Mr 43,000 protein was immunoprecipitated by polyclonal antibodies to the Zn-alpha 2-glycoprotein. A Mr 18,000 and a Mr 13,000 polypeptide were both immunoprecipitated by four monoclonal antibodies directed against four separate epitopes of Mr 15,000 gross cystic disease fluid protein, a major protein that is characteristic of apocrine gland secretions. In sodium dodecyl sulfate-polyacrylamide gel electrophoresis, purified Mr 15,000 gross cystic disease fluid protein migrated at the level of the Mr 18,000 protein of T47D cells. The proteins were regulated by androgens and progestins. In addition to a general stimulation of protein secretion, 5 alpha-dihydrotestosterone (DHT) specifically increased, by 2- to 20-fold, the release of the Mr 43,000 and Mr 18,000 proteins into the medium. DHT also increased the cellular level of the Mr 18,000 protein, as shown by immunoprecipitation with a Mr 15,000 gross cystic disease fluid protein antibody, which suggests a stimulation of protein synthesis. The progestin 17,21-dimethyl-19-nor-4,9-pregnadiene-3,20-dione also increased the release in the medium of the Mr 43,000 and Mr 18,000 proteins, but higher molar concentrations were required than in the case of DHT. The induction of these proteins by DHT and 17,21-dimethyl-19nor,4,9-pregnadiene-3,20-dione was specifically inhibited by the antiandrogen flutamide which has no effect on other progestin-regulated proteins. This suggests an effect mediated by the androgen receptor. This is the first report on the identification of two proteins induced by androgens in a human breast cancer cell line. These proteins should be useful in studying the role of androgens in human mammary tumors and their mechanism of action in cell culture.
T47D人乳腺癌细胞释放的三种[35S]甲硫氨酸标记的多肽已被鉴定为与先前在乳腺大囊性病液中描述的两种蛋白质相对应。一种43000道尔顿的蛋白质被针对锌-α2-糖蛋白的多克隆抗体免疫沉淀。一种18000道尔顿和一种13000道尔顿的多肽都被针对15000道尔顿大囊性病液蛋白的四个不同表位的四种单克隆抗体免疫沉淀,15000道尔顿大囊性病液蛋白是顶泌腺分泌物特有的一种主要蛋白质。在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳中,纯化的15000道尔顿大囊性病液蛋白在T47D细胞18000道尔顿蛋白质的水平处迁移。这些蛋白质受雄激素和孕激素调节。除了对蛋白质分泌有一般刺激作用外,5α-二氢睾酮(DHT)使43000道尔顿和18000道尔顿蛋白质释放到培养基中的量特异性增加2至20倍。DHT还增加了18000道尔顿蛋白质的细胞水平,用15000道尔顿大囊性病液蛋白抗体进行免疫沉淀显示了这一点,这表明对蛋白质合成有刺激作用。孕激素17,21-二甲基-19-去甲-4,9-孕二烯-3,20-二酮也增加了43000道尔顿和18000道尔顿蛋白质在培养基中的释放,但所需的摩尔浓度比DHT的情况更高。DHT和17,21-二甲基-19-去甲-4,9-孕二烯-3,20-二酮对这些蛋白质的诱导被抗雄激素氟他胺特异性抑制,氟他胺对其他孕激素调节的蛋白质没有影响。这表明是由雄激素受体介导的作用。这是关于在人乳腺癌细胞系中鉴定两种由雄激素诱导的蛋白质的首次报道。这些蛋白质在研究雄激素在人乳腺肿瘤中的作用及其在细胞培养中的作用机制方面应该是有用的。